Health care stocks were lower Monday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each shedding about 0.5%.
The iShares Biotechnology ETF (IBB) rose 0.9%.
In corporate news, President-elect Donald Trump told reporters his administration is going to "knock out" pharmacy benefit managers in an effort to bring down drug prices, Bloomberg reported. Shares of UnitedHealth (UNH), CVS Health (CVS) and Cigna (CI), which own the three largest pharmacy benefit managers, were falling 3.4%, 3.9% and 1.8% respectively.
Maia Biotechnology (MAIA) shares jumped over 8% after the firm said its investigational telomere-targeting agent THIO received a rare pediatric disease designation from the US Food and Drug Administration to treat pediatric-type diffuse high-grade gliomas.
Catalent (CTLT) and Novo Nordisk (NVO) said that they have completed all regulatory closing conditions for Novo's pending acquisition of Catalent. Catalent shares rose 0.6%, and Novo added 1.5%.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。